Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of the present study was to characterize the human Helios gene products expressed in
leukemia
cells. A 3.5 kb human Helios cDNA clone was isolated from a human T-cell cDNA library derived from the human T-acute lymphoblastic leukemia (ALL) cell line JURKAT. This cDNA clone had a unique open reading frame (ORF) encoding a novel 304 amino acid (AA) peptide, which was designated as
Helios 3
. The sequence of the 289 AA C-terminal portion of
Helios 3
downstream of V-16 is identical to the corresponding sequence found in Helios 1 and 2 and contains two zinc fingers. By contrast, the 15 AA N-terminal portion of
Helios 3
is unique and does not contain the N-terminal zinc finger motifs that are conserved in Helios 1 and 2 as well as other previously identified members of the Ikaros family. Southern blot analysis of genomic DNA fragments of the human Helios gene locus showed that
Helios 3
is encoded by the same genomic locus as Helios 1 and 2. The expression of
Helios 3
mRNA was not restricted to T-lineage ALL cells or another immunophenotypically distinct subset of leukemias.
Helios 3
mRNA was expressed in freshly obtained primary leukemic cells from six of 15 children with newly diagnosed ALL.
Helios 3
exhibited a unique protein interaction profile via its N-terminal portion, which may have biological significance in pathogenesis of human leukemias.
...
PMID:Expression of a unique helios isoform in human leukemia cells. 1215 74